CYP17A1 Inhibitor

4-Pyridylmethyl adamantanecarboxamide (Compound 11) is an Aromatase inhibitor with an IC₅₀ of 1.5 μM against hAromatase. 4-Pyridylmethyl adamantanecarboxamide inhibits the C17,20-lyase activity of testicular cytochrome P450_17α with an IC₅₀ of 1600 nM, and also inhibits the 17α-hydroxylase activity of this enzyme with an IC₅₀ of 7700 nM. 4-Pyridylmethyl adamantanecarboxamide can be used in the research of prostate cancer.

CYP17A1/HDAC6-IN-1 (compound 12) is a potent inhibitor of CYP17A1/HDAC6, with IC₅₀ of 0.284μM and 0.6015 μM,respectively. CYP17A1/HDAC6-IN-1 has anti-tumor activity.

ASN-001 is an orally active CYP-17A1 lyase inhibitor that selectively inhibits testosterone synthesis. ASN-001 has anticancer activity and can be used for research in the field of prostate cancer.

CYP17A1-IN-2 is a potent inhibitor of CYP17A1. CYP17A1-IN-2 exhibits anti-proliferative activity against prostate cancer cells. CYP17A1-IN-2 can be used in research related to castration-resistant prostate cancer.